Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer

Background Interactions among genetic variants are rarely studied but may explain a part of the variability in patient outcomes. Objectives In this study, we aimed to identify 1 to 3 way interactions among SNPs from five Wnt protein interaction networks that predict the 5-year recurrence risk in a c...

Full description

Bibliographic Details
Published in:Frontiers in Oncology
Main Authors: Curtis, Aaron A., Yu, Yajun, Carey, Megan, Parfrey, Patrick, Yilmaz, Yildiz E., Savas, Sevtap
Other Authors: Memorial University of Newfoundland
Format: Article in Journal/Newspaper
Language:unknown
Published: Frontiers Media SA 2023
Subjects:
Online Access:http://dx.doi.org/10.3389/fonc.2023.1122229
https://www.frontiersin.org/articles/10.3389/fonc.2023.1122229/full
id crfrontiers:10.3389/fonc.2023.1122229
record_format openpolar
spelling crfrontiers:10.3389/fonc.2023.1122229 2024-02-11T10:05:58+01:00 Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer Curtis, Aaron A. Yu, Yajun Carey, Megan Parfrey, Patrick Yilmaz, Yildiz E. Savas, Sevtap Memorial University of Newfoundland 2023 http://dx.doi.org/10.3389/fonc.2023.1122229 https://www.frontiersin.org/articles/10.3389/fonc.2023.1122229/full unknown Frontiers Media SA https://creativecommons.org/licenses/by/4.0/ Frontiers in Oncology volume 13 ISSN 2234-943X Cancer Research Oncology journal-article 2023 crfrontiers https://doi.org/10.3389/fonc.2023.1122229 2024-01-26T10:06:31Z Background Interactions among genetic variants are rarely studied but may explain a part of the variability in patient outcomes. Objectives In this study, we aimed to identify 1 to 3 way interactions among SNPs from five Wnt protein interaction networks that predict the 5-year recurrence risk in a cohort of stage I-III colorectal cancer patients. Methods 423 patients recruited to the Newfoundland Familial Colorectal Cancer Registry were included. Five Wnt family member proteins (Wnt1, Wnt2, Wnt5a, Wnt5b, and Wnt11) were selected. The BioGRID database was used to identify the proteins interacting with each of these proteins. Genotypes of the SNPs located in the interaction network genes were retrieved from a genome-wide SNP genotype data previously obtained in the patient cohort. The GMDR 0.9 program was utilized to examine 1-, 2-, and 3-SNP interactions using a 5-fold cross validation step. Top GMDR 0.9 models were assessed by permutation testing and, if significant, prognostic associations were verified by multivariable logistic regression models. Results GMDR 0.9 has identified novel 1, 2, and 3-way SNP interactions associated with 5-year recurrence risk in colorectal cancer. Nine of these interactions were multi loci interactions (2-way or 3-way). Identified interaction models were able to distinguish patients based on their 5-year recurrence-free status in multivariable regression models. The significance of interactions was the highest in the 3-SNP models. Several of the identified SNPs were eQTLs, indicating potential biological roles of the genes they were associated with in colorectal cancer recurrence. Conclusions We identified novel interacting genetic variants that associate with 5-year recurrence risk in colorectal cancer. A significant portion of the genes identified were previously linked to colorectal cancer pathogenesis or progression. These variants and genes are of interest for future functional and prognostic studies. Our results provide further evidence for the utility of GMDR models in ... Article in Journal/Newspaper Newfoundland Frontiers (Publisher) Frontiers in Oncology 13
institution Open Polar
collection Frontiers (Publisher)
op_collection_id crfrontiers
language unknown
topic Cancer Research
Oncology
spellingShingle Cancer Research
Oncology
Curtis, Aaron A.
Yu, Yajun
Carey, Megan
Parfrey, Patrick
Yilmaz, Yildiz E.
Savas, Sevtap
Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer
topic_facet Cancer Research
Oncology
description Background Interactions among genetic variants are rarely studied but may explain a part of the variability in patient outcomes. Objectives In this study, we aimed to identify 1 to 3 way interactions among SNPs from five Wnt protein interaction networks that predict the 5-year recurrence risk in a cohort of stage I-III colorectal cancer patients. Methods 423 patients recruited to the Newfoundland Familial Colorectal Cancer Registry were included. Five Wnt family member proteins (Wnt1, Wnt2, Wnt5a, Wnt5b, and Wnt11) were selected. The BioGRID database was used to identify the proteins interacting with each of these proteins. Genotypes of the SNPs located in the interaction network genes were retrieved from a genome-wide SNP genotype data previously obtained in the patient cohort. The GMDR 0.9 program was utilized to examine 1-, 2-, and 3-SNP interactions using a 5-fold cross validation step. Top GMDR 0.9 models were assessed by permutation testing and, if significant, prognostic associations were verified by multivariable logistic regression models. Results GMDR 0.9 has identified novel 1, 2, and 3-way SNP interactions associated with 5-year recurrence risk in colorectal cancer. Nine of these interactions were multi loci interactions (2-way or 3-way). Identified interaction models were able to distinguish patients based on their 5-year recurrence-free status in multivariable regression models. The significance of interactions was the highest in the 3-SNP models. Several of the identified SNPs were eQTLs, indicating potential biological roles of the genes they were associated with in colorectal cancer recurrence. Conclusions We identified novel interacting genetic variants that associate with 5-year recurrence risk in colorectal cancer. A significant portion of the genes identified were previously linked to colorectal cancer pathogenesis or progression. These variants and genes are of interest for future functional and prognostic studies. Our results provide further evidence for the utility of GMDR models in ...
author2 Memorial University of Newfoundland
format Article in Journal/Newspaper
author Curtis, Aaron A.
Yu, Yajun
Carey, Megan
Parfrey, Patrick
Yilmaz, Yildiz E.
Savas, Sevtap
author_facet Curtis, Aaron A.
Yu, Yajun
Carey, Megan
Parfrey, Patrick
Yilmaz, Yildiz E.
Savas, Sevtap
author_sort Curtis, Aaron A.
title Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer
title_short Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer
title_full Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer
title_fullStr Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer
title_full_unstemmed Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer
title_sort multifactor dimensionality reduction method identifies novel snp interactions in the wnt protein interaction networks that are associated with recurrence risk in colorectal cancer
publisher Frontiers Media SA
publishDate 2023
url http://dx.doi.org/10.3389/fonc.2023.1122229
https://www.frontiersin.org/articles/10.3389/fonc.2023.1122229/full
genre Newfoundland
genre_facet Newfoundland
op_source Frontiers in Oncology
volume 13
ISSN 2234-943X
op_rights https://creativecommons.org/licenses/by/4.0/
op_doi https://doi.org/10.3389/fonc.2023.1122229
container_title Frontiers in Oncology
container_volume 13
_version_ 1790603331066920960